159 related articles for article (PubMed ID: 31666643)
1. Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model.
Park HJ; Han H; Oh EY; Kim SR; Park KH; Lee JH; Park JW
Sci Rep; 2019 Oct; 9(1):15601. PubMed ID: 31666643
[TBL] [Abstract][Full Text] [Related]
2. Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.
Chiou HC; Lin MW; Hsiao PJ; Chen CL; Chiao S; Lin TY; Chen YC; Wu DC; Lin MH
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934882
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance mediates high-fat diet-induced pulmonary fibrosis and airway hyperresponsiveness through the TGF-β1 pathway.
Park YH; Oh EY; Han H; Yang M; Park HJ; Park KH; Lee JH; Park JW
Exp Mol Med; 2019 May; 51(5):1-12. PubMed ID: 31133649
[TBL] [Abstract][Full Text] [Related]
4. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.
Xu L; Nagata N; Chen G; Nagashimada M; Zhuge F; Ni Y; Sakai Y; Kaneko S; Ota T
BMJ Open Diabetes Res Care; 2019; 7(1):e000783. PubMed ID: 31749970
[TBL] [Abstract][Full Text] [Related]
5. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
6. Obesity-induced Vitamin D Deficiency Contributes to Lung Fibrosis and Airway Hyperresponsiveness.
Han H; Chung SI; Park HJ; Oh EY; Kim SR; Park KH; Lee JH; Park JW
Am J Respir Cell Mol Biol; 2021 Mar; 64(3):357-367. PubMed ID: 33296297
[TBL] [Abstract][Full Text] [Related]
7. Roflumilast Ameliorates Airway Hyperresponsiveness Caused by Diet-Induced Obesity in a Murine Model.
Park HJ; Lee JH; Park YH; Han H; Sim da W; Park KH; Park JW
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):82-91. PubMed ID: 26756251
[TBL] [Abstract][Full Text] [Related]
8. [Dulaglutide (Trulicity®), a new once-weekly agonist of glucagon-like peptide-1 receptors for type 2 diabetes].
Scheen AJ
Rev Med Liege; 2016 Mar; 71(3):154-60. PubMed ID: 27311248
[TBL] [Abstract][Full Text] [Related]
9. Pravastatin alleviates allergic airway inflammation in obesity-related asthma mouse model.
Lee HY; Lee EG; Hur J; Rhee CK; Kim YK; Lee SY; Kang JY
Exp Lung Res; 2019; 45(9-10):275-287. PubMed ID: 31608695
[No Abstract] [Full Text] [Related]
10. Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis.
Kabel AM; Estfanous RS; Alrobaian MM
Respir Physiol Neurobiol; 2020 Feb; 273():103316. PubMed ID: 31600583
[TBL] [Abstract][Full Text] [Related]
11. Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.
Scheen AJ
Expert Rev Clin Pharmacol; 2016; 9(3):385-99. PubMed ID: 26761217
[TBL] [Abstract][Full Text] [Related]
12. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
[TBL] [Abstract][Full Text] [Related]
13. Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model.
Liang L; Hur J; Kang JY; Rhee CK; Kim YK; Lee SY
Korean J Intern Med; 2018 Nov; 33(6):1210-1223. PubMed ID: 29665658
[TBL] [Abstract][Full Text] [Related]
14. Weight loss in patients with type 2 diabetes receiving once-weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post-hoc analysis of the AWARD-4 study across baseline body mass index subgroups.
Fuechtenbusch M; Aberle J; Heitmann E; Nicolay C; Jung H
Diabetes Obes Metab; 2019 Jun; 21(6):1340-1348. PubMed ID: 30737891
[TBL] [Abstract][Full Text] [Related]
15. Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.
Kimura T; Obata A; Shimoda M; Hirukawa H; Kanda-Kimura Y; Nogami Y; Kohara K; Nakanishi S; Mune T; Kaku K; Kaneto H
Diabetes Metab; 2018 Jun; 44(3):250-260. PubMed ID: 29525225
[TBL] [Abstract][Full Text] [Related]
16. Dulaglutide mitigates inflammatory response in fibroblast-like synoviocytes.
Zheng W; Pan H; Wei L; Gao F; Lin X
Int Immunopharmacol; 2019 Sep; 74():105649. PubMed ID: 31185450
[TBL] [Abstract][Full Text] [Related]
17. Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation.
Luo X; Hu Y; He S; Ye Q; Lv Z; Liu J; Chen X
Arch Biochem Biophys; 2019 Aug; 671():203-209. PubMed ID: 31302140
[TBL] [Abstract][Full Text] [Related]
18. Effects of chitinase-1 inhibitor in obesity-induced and -aggravated asthma in a murine model.
Han H; Choi YJ; Hong H; Kim CY; Byun MK; Cho JH; Lee JH; Park JW; Doherty TA; Park HJ
Life Sci; 2023 Dec; 334():122163. PubMed ID: 37890698
[TBL] [Abstract][Full Text] [Related]
19. High fat diet induces airway hyperresponsiveness in mice.
Fricke K; Vieira M; Younas H; Shin MK; Bevans-Fonti S; Berger S; Lee R; D'Alessio FR; Zhong Q; Nelson A; Loube J; Sanchez I; Hansel NN; Mitzner W; Polotsky VY
Sci Rep; 2018 Apr; 8(1):6404. PubMed ID: 29686414
[TBL] [Abstract][Full Text] [Related]
20. Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months.
Moreno Obregón F; Miramontes-González JP; Romo Guajardo-Fajardo C; Nieto-Sánchez Á; López-Suárez JM; Martín-Vallejo J; Arco-Prados Y; Dolores García de Lucas M; León-Jiménez D
Diabetes Res Clin Pract; 2019 Dec; 158():107916. PubMed ID: 31682882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
